lamivudine has been researched along with Liver Dysfunction in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (93.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellini, C; Bernasconi, E; Cavassini, M; Chave, JP; Evison, J; Fehr, J; Kaiser, L; Keiser, O; Telenti, A; Vernazza, P; Weber, R | 1 |
| Cappelli, B; Faraci, M; Fioredda, F; Giacchino, R; Giudice, CL; Lanino, E; Morreale, G | 1 |
| Naggie, S; Sulkowski, MS | 1 |
| Maeda, Y; Okamoto, R; Sasaki, T | 1 |
| Chan, HL; Chan, JY; Cheng, AS; Go, MY; Leung, WK; Liew, CT; Sung, JJ; To, KF | 1 |
| Murphy, MJ; Wilcox, RD | 1 |
| Maier, KP | 1 |
| Eguchi, K; Fukushima, T; Gotoh, T; Hayashi, T; Ichikawa, T; Ida, H; Kawakami, A; Nakamura, H; Takeshita, S; Toriyama, K; Tsujino, A | 1 |
| Choi, KH; Hong, SP; Hwang, SG; Kim, S; Ko, KH; Kwon, CI; Lee, JH; Oh, D; Park, PW; Rim, KS | 1 |
| Angus, PW; Crawford, DH; Gane, EJ; Jeffrey, GP; McCaughan, GW; Ring, J; Strasser, S | 1 |
| Guillemi, S; Gutiérrez, S; Harrigan, PR; Jahnke, N; Montaner, JS; Montessori, V | 1 |
| Maddrey, WC | 1 |
| Han, DJ; Jung, JG; Kim, SB; Kim, SC; Kim, TH; Lee, SK; Park, JS; Park, SK; Yang, WS; Yu, ES | 1 |
| Huang, D; Liang, T; Liao Sy, SY; Lu Aw, AW; Shen, Y; Wang, W; Wu, J; Xu, X; Zhang, M; Zheng, S | 1 |
| Asaka, M; Chiba, K; Hashino, S; Hige, S; Izumiyama, K; Nozawa, A; Suzuki, S; Takahata, M | 1 |
4 review(s) available for lamivudine and Liver Dysfunction
| Article | Year |
|---|---|
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Diseases; Male; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Substance Abuse, Intravenous; Tenofovir; Treatment Outcome | 2012 |
[Hepatotoxicity of chemotherapy].
Topics: Antineoplastic Agents; Antiviral Agents; Chemical and Drug Induced Liver Injury; Hematologic Neoplasms; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Liver Diseases; Neoplasms; Reverse Transcriptase Inhibitors | 2003 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Fatty Liver; Hemochromatosis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Interferons; Lamivudine; Liver Cirrhosis, Biliary; Liver Diseases; Organophosphonates; Prednisolone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors | 2005 |
Hepatitis B--an important public health issue.
Topics: Antiviral Agents; Carrier State; Endemic Diseases; Hepatitis B; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Diseases; Public Health | 2001 |
1 trial(s) available for lamivudine and Liver Dysfunction
| Article | Year |
|---|---|
Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence.
Topics: DNA, Viral; Female; Graft Rejection; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Diseases; Male; Recurrence; Reverse Transcriptase Inhibitors; Salvage Therapy | 2001 |
10 other study(ies) available for lamivudine and Liver Dysfunction
| Article | Year |
|---|---|
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Hepatitis B; Hepatitis B e Antigens; HIV-1; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Recurrence; Switzerland; Viral Load | 2009 |
Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: a pediatric experience.
Topics: Adolescent; Antiviral Agents; Child; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Diseases; Male; Transplantation, Homologous; Treatment Outcome; Virus Activation | 2009 |
Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2.
Topics: Anti-HIV Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Green Fluorescent Proteins; Hepatitis B, Chronic; Humans; Immunohistochemistry; Interferons; Isoenzymes; Lamivudine; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Membrane Proteins; Microscopy, Fluorescence; Plasmids; Prostaglandin-Endoperoxide Synthases; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trans-Activators; Transfection; Viral Regulatory and Accessory Proteins | 2004 |
Management of the coinfected patient: human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic Disease; Contraindications; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Liver Diseases; Nucleosides; Practice Guidelines as Topic | 2004 |
Hepatitis B-related polyarteritis nodosa presenting necrotizing vasculitis in the hepatobiliary system successfully treated with lamivudine, plasmapheresis and glucocorticoid.
Topics: Antiviral Agents; Cholecystitis; Gallbladder Diseases; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Plasmapheresis; Polyarteritis Nodosa | 2006 |
[Hepatitis B and C virus infection and liver dysfunction in patients receiving chemotherapy].
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Chemical and Drug Induced Liver Injury; Female; Hepatitis B; Hepatitis C; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Neoplasms; Prevalence | 2006 |
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
Topics: Adult; Aged; Antiviral Agents; Australia; Disease-Free Survival; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Kaplan-Meier Estimate; Lamivudine; Liver Diseases; Liver Transplantation; Male; Middle Aged; New Zealand; Postoperative Complications; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Secondary Prevention; Time Factors; Treatment Outcome | 2007 |
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Homosexuality, Male; Humans; Lamivudine; Liver Diseases; Male; Organophosphonates; Tenofovir; Transaminases; Viral Load | 2008 |
[Orthotopic liver transplantation for end-stage liver diseases in 71 cases].
Topics: Adolescent; Adult; Biliary Tract Diseases; Child; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Rate; Vascular Diseases | 2002 |
Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine.
Topics: Adult; Anemia, Aplastic; Antiviral Agents; Bone Marrow Transplantation; Disease-Free Survival; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Diseases; Tissue Donors; Transplantation, Homologous; Virus Activation | 2002 |